TrialArthritis research & therapy2018

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology.

Xavier M Teitsma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.